American drugmaker Gilead Sciences, which has developed the antiviral remdesivir shown to be effective against the coronavirus, was targeted by hackers with ties to Iran, Reuters reported on Friday. Iran-linked hackers carried out multiple attempts to gain access to Gilead employee emails in recent weeks, the news agency said, based on its review of web archives and interviews with three cybersecurity researchers. Citing an intelligence researcher at Israeli cybersecurity firm ...